THE FUTURE OF BREAST CANCER RESEARCH
Imagine, if there could be a fairly straight forward, wearable technology; a bioreactor bra, which would disrupt and halt the proliferation of early tumors?
Is it possible to actually target and disrupt fast-dividing precancerous stem cells long before they become a cancer?
Simply put - is it possible to actually prevent breast cancer?
After 100 years of using the destructive power of radiation upon tumor and cancer cells what is needed in the art and has not been available is an apparatus for destroying dividing cells, wherein the apparatus better discriminates between dividing cells, and non-dividing cells and is capable of selectively destroying the dividing cells or organisms with substantially no effect on the non-dividing cells or organisms.
Imagine if there was another, completely fresh new way, to see this challenge!
We discovered a completely new branch of cancer research, where it seems that few, if any, have journeyed before. We need to look at the actual development of the cancers at their earliest development.
The facts are now clear. Cancer is caused by rogue cancer stem cells!
However, before a cancer stem cell actually becomes a cancer, it is a precancerous stem cell. And before that, it is an early tumor. We believe the key is the vulnerability of the fast-dividing cells in early tumors.
There is no cure for cancer. Cancer is a complex multi-phased disease that progresses through many phases over a long time. Before cancer actually becomes “cancerous”, is a phase we call pre-cancerous, and our scientists have discovered that very early, fast dividing precancerous cells, may be vulnerable to various disruptive therapies.
A major use of the present apparatus is in the treatment of tumors by selective destruction of tumor cells with substantially no effect on normal tissue cells, and thus, the apparatus is efficient at the destruction of tumor cells. The apparatus enables selective destruction of cells undergoing division in a way that is more effective and more accurate (e.g., more adaptable to be aimed at specific targets) than existing methods. Further, the present apparatus causes minimal damage, if any, to normal tissue and, thus, reduces or eliminates many side-effects associated with existing selective destruction methods, such as radiation therapy and chemotherapy. The selective destruction of dividing cells using the present apparatus does not depend on the sensitivity of the cells to chemical agents or radiation. Instead, the selective destruction of dividing cells is based on distinguishable geometrical characteristics of cells undergoing division, in comparison to non-dividing cells, regardless of the cell geometry of the type of cells being treated.
Research into the disruption of early fast-dividing precancerous stem cells is ongoing. New clinical studies are planned and patients are encouraged to enroll. For information, please contact us.
Statistics at a Glance: The Burden of Cancer Worldwide
Almost 10 Million people die from cancer annually
Cancer is one of the world’s largest health problems. The Global Burden of Disease estimates that 9.56 million people died prematurely as a result of cancer in 2018. Every sixth death in the world is due to cancer
In 2015, there were 14.1 million new cases and 8.2 million cancer-related deaths worldwide.
The number of new cancer cases per year is expected to rise to 23.6 million by 2030.
Breast cancer in the US is expected to double by 2030, with 400,000 new cases and 80,000 deaths.
These shocking facts fly in the face of pharma companies and cancer charities which claim we are winning this fight. This is simply not true.
We believe that new ways must be developed for earlier and better imaging and detection, and tumors must be targeted when they are very small and precancerous with advanced therapies such as the Breast Shield Defender Bra, which may slow or even prevent breast cancer, and was featured on the CBS Evening News as a major discovery.
We need to do something NOW…not someday.
Prevention is the Cure!